产品描述
CRISPR基因编辑技术是继TALEN、ZFN技术之后的重大突破，通过gRNA指导核酸酶（如Cas9）对目的基因进行特定编辑。CRISPR-Cas9系统的基因编辑效率高，操作简便，可设计性丰富，基于gRNA或Cas9载体构建与使用现已非常便捷，已应用于哺乳动物、植物及其他物种中的基因编辑实验中，尤其是基于AAV载体的CRISPR-Cas9或CRISPR-Cpf1是目前广泛使用的基因编辑技术，诞生了很多突破性的发现并越来越多地运用于新药开发与临床研究中。
| 编号 | 血清型 | Cas核酸酶类型 | 滴度、体积 |
| AAV9-A2 | AAV9 | EFS.SpCas9 | ≥1E+13 GC/mL， 0.1 mL |
| AAV9-B2 | EFS.SpCas9HF | ||
| AAV9-B202 | miniCMV.SpCas9HF | ||
| AAV9-C202 | miniCMV.SaCas9 | ||
| AAV9-C2 | CMV.SaCas9 | ||
| AAV9-D2 | CMV.SaCas9HF | ||
| AAV9-G101 | EFS.AsCpf1 | ||
| AAV9-H101 | EFS.LbCpf1 | ||
| AAV9-G102 | miniCMV.AsCpf1 | ||
| AAV9-H102 | miniCMV.LbCpf1 | ||
| AAV9-C202* | EFS.SaCas9 | ||
| AAV9-C206 | AAV9 | Elastase I.SaCas9 | ≥1E+13 GC/mL， 0.1 mL |
| AAV9-C207 | rInsulin 2.SaCas9 | ||
| AAV9-C208 | mInsulin2.SaCas9 | ||
| AAV9-C209 | hDesmin.SaCas9 | ||
| AAV9-C210 | hSynapsin.SaCas9 | ||
| AAV9-C212 | MECP2.SaCas9 | ||
| AAV9-D2* | CMV.SaCas9HF | ||
| AAV9-D202 | EFS.SaCas9HF | ||
| AAV9-D206 | Elastase I.SaCas9HF | ||
| AAV9-D207 | rInsulin 2.SaCas9HF | ||
| AAV9-D208 | mInsulin2.SaCas9 | ||
| AAV9-D209 | hDesmin.SaCas9 | ||
| AAV9-D210 | hSynapsin.SaCas9 | ||
| AAV9-D212 | MECP2.SaCas9 |
派真生物提供以AAV包装的Cas9和Cpf1载体，可以直接、方便、高效地应用于动物实验，每一款现货产品都提供完整的质检报告。
货号 | 产品描述 | 价格（￥） | 货期 |
AAV9-A2-50 | AAV9 [EFS.SpCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-A2-500 | AAV9 [EFS.SpCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-B2-50 | AAV9 [EFS.SpCas9HF],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-B2-500 | AAV9 [EFS.SpCas9HF],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-B202-50 | AAV9 [miniCMV.SpCas9HF],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-B202-500 | AAV9 [miniCMV.SpCas9HF],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C202-50 | AAV9 [EFS.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C202-500 | AAV9 [EFS.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C2-50 | AAV9 [CMV.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C2-500 | AAV9 [CMV.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D2-50 | AAV9 [CMV.SaCas9HF],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D2-500 | AAV9 [CMV.SaCas9HF],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D202-50 | AAV9 [EFS.SaCas9HF],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D202-500 | AAV9 [EFS.SaCas9HF],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-G101-50 | AAV9 [EFS.AsCpf1],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-G101-500 | AAV9 [EFS.AsCpf1],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-H101-50 | AAV9 [EFS.LbCpf1],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-H101-500 | AAV9 [EFS.LbCpf1],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-G102-50 | AAV9 [miniCMV.AsCpf1],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-G102-500 | AAV9 [miniCMV.AsCpf1],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-H102-50 | AAV9 [miniCMV.LbCpf1],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-H102-500 | AAV9 [miniCMV.LbCpf1],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C201-50 | AAV9 [TBG.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C201-500 | AAV9 [TBG.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C206-50 | AAV9 [Elastase I.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C206-500 | AAV9 [Elastase I.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C207-50 | AAV9 [rInsulin 2.SaCas9]≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C207-500 | AAV9 [rInsulin 2.SaCas9]≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C208-50 | AAV9 [mInsulin2.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C208-500 | AAV9 [mInsulin2.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C209-50 | AAV9 [hDesmin.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C209-500 | AAV9 [hDesmin.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C210-50 | AAV9 [hSynapsin.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C210-500 | AAV9 [hSynapsin.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-C212-50 | AAV9 [MECP2.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-C212-500 | AAV9 [MECP2.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D201-50 | AAV9 [TBG.SaCas9HF],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D201-500 | AAV9 [TBG.SaCas9HF],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D206-50 | AAV9 [Elastase I.SaCas9HF],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D206-500 | AAV9 [Elastase I.SaCas9HF],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D207-50 | AAV9 [rInsulin 2.SaCas9HF],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D207-500 | AAV9 [rInsulin 2.SaCas9HF],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D208-50 | AAV9 [mInsulin2.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D208-500 | AAV9 [mInsulin2.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D209-50 | AAV9 [hDesmin.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D209-500 | AAV9 [hDesmin.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D210-50 | AAV9 [hSynapsin.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D210-500 | AAV9 [hSynapsin.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
AAV9-D212-50 | AAV9 [MECP2.SaCas9],≥1E+13 GC/mL,50ul | ￥1,380 | 24h |
AAV9-D212-500 | AAV9 [MECP2.SaCas9],≥1E+13 GC/mL,500ul | ￥10,480 | 24h |
